|
⚲
|
| Keyboard |
| Corcept Therapeutics Inc | |
|---|---|
| Ticker | CORT |
| CIK # | 0001088856 |
| CUSIP | 218352102 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 149 Commonwealth Drive, Menlo Park, CA 94025 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Corcept Therapeutics Inc | 2012-04-10 | 0.5 M | Exemption: 506 · Remaining: $17,019,895 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001088856] | 10-K | |
| [0001088856] | 10-Q | |
| [0001088856] | 3 | |
| [0001088856] | 4 | |
| [0001088856] | 5 | |
| [0001088856] | 8-K | |
| [0001088856] | D | |
| [0001088856] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| BlackRock Inc | Corcept Therapeutics Inc | [2023-01-20] | 15.2 |
| Baker G Leonard Jr | Corcept Therapeutics Inc | [2022-02-14] | 5.2 |
| Belanoff Joseph K | Corcept Therapeutics Inc | [2021-02-11] | 5.3 |
| Renaissance Technologies LLC | Corcept Therapeutics Inc | [2020-02-12] | 6.8 |
| Consonance Capital Management LP | Corcept Therapeutics Inc | [2018-02-14] | 4.98 |
| Vanguard Group Inc | Corcept Therapeutics Inc | [2018-02-08] | 8.21 |
| BlackRock Inc | Corcept Therapeutics Inc | [2017-01-30] | 5.5 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Belanoff Joseph K
Common Stock
|
2026-03-25 | Sell | 26,198 | $50.07 | 1,311,734 |
|
Guyer William
Common Stock
|
2026-03-20 | Option exercise | 11,767 | $21.65 | 254,756 |
|
Wilson James N
Common Stock
|
2026-03-20 | Gift | 4,000 | $0.00 | |
|
Guyer William
Common Stock
|
2026-03-20 | Sell | 11,767 | $36.01 | 423,730 |
|
Guyer William
Stock Option (right to buy) · derivative
|
2026-03-20 | Option exercise | 11,767 | $0.00 | |
|
Baker G Leonard Jr
Common Stock
|
2026-03-17 | Buy | 24,218 | $33.56 | 812,756 |
|
Baker G Leonard Jr
Common Stock
|
2026-03-17 | Buy | 75,782 | $33.00 | 2,500,806 |
|
Wilson James N
Common Stock
|
2026-03-13 | Gift | 28,000 | $0.00 | |
|
Mahoney David L
Common Stock
|
2026-03-13 | Other | 24,531 | $0.00 | |
|
Mahoney David L
Common Stock
|
2026-03-13 | Tax withheld | 5,469 | $32.15 | 175,828 |
|
Mahoney David L
Common Stock
|
2026-03-13 | Gift | 24,531 | $0.00 | |
|
Mahoney David L
Common Stock
|
2026-03-13 | Option exercise | 30,000 | $5.86 | 175,800 |
|
Mahoney David L
Stock Option (right to buy) · derivative
|
2026-03-13 | Option exercise | 30,000 | $0.00 | |
|
Guyer William
Common Stock
|
2026-03-04 | Option exercise | 8,233 | $21.65 | 178,244 |
|
Guyer William
Stock Option (right to buy) · derivative
|
2026-03-04 | Option exercise | 8,233 | $0.00 | |
|
Guyer William
Common Stock
|
2026-03-04 | Sell | 8,233 | $35.99 | 296,306 |
|
Lyon Joseph Douglas
Common Stock
|
2026-03-03 | Tax withheld | 89 | $35.97 | 3,201 |
|
Robb Gary Charles
Common Stock
|
2026-03-03 | Tax withheld | 121 | $35.97 | 4,352 |
|
Mokari Atabak
Common Stock
|
2026-03-03 | Tax withheld | 96 | $35.97 | 3,453 |
|
Maduck Sean
Common Stock
|
2026-03-03 | Tax withheld | 110 | $35.97 | 3,957 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 352 | 74,603,407 |
| 2025-12-31 | 396 | 74,918,406 |
| 2025-09-30 | 435 | 70,718,033 |
| 2025-06-30 | 427 | 71,669,374 |
| 2025-03-31 | 433 | 76,707,874 |
| 2024-12-31 | 376 | 78,086,093 |
| 2024-09-30 | 327 | 81,789,175 |
| 2024-06-30 | 291 | 81,023,653 |
| 2024-03-31 | 292 | 83,916,985 |
| 2023-12-31 | 279 | 71,335,769 |
| 2023-09-30 | 249 | 67,610,869 |
| 2023-06-30 | 226 | 66,056,330 |